The state of Georgia currently has 13 active clinical trials seeking participants for Pancreatic Cancer research studies. These trials are conducted in various cities, including Atlanta, Augusta, Decatur and Savannah.
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Recruiting
The study is a multi-center, un-blinded, randomized control study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/23/2022
Locations: Piedmont-Columbus Regional - John B. Amos Cancer Center, Columbus, Georgia
Conditions: Locally Advanced Pancreatic Cancer